
Benjamin Louis Yudkoff MD MA
Chief Medical Officer and Co-Founder - Lumin Health (luminhealth.com)
Join to view full profile
10 Langley RdSte 303Newton, MA 02459
Phone+1 617-863-8810
Fax+1 617-863-8844
Dr. Yudkoff is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Benjamin Yudkoff is co-founder and CMO of Lumin Health - a ketamine and esketamine medical practice with locations in the Boston metro area and the DC area. By way of background: Dr. Yudkoff was the director of the Brigham and Women's Faulkner Hospital Partial Hospital Program and Psychiatric Intervention program. He spearheaded the development of the long acting injectable antipsychotic clinic, the outpatient ECT program, and the ketamine and esketamine program. Specializing in treatment refractory psychiatric illness and program development, he co-founded Lumin Health in 2022 to address treatment refractory depression. Lumin Health is an academically-oriented commercial enterprise. Residents, fellows, and nurse practitioner students train in Lumin Health sites.
Dr. Yudkoff has received several teaching and professional awards, including honors from Harvard Medical School and the Gold Humanism Society. He continues to supervise Harvard Medical School - Brigham and Women's Hospital residents in psychodynamic psychotherapy.
Education & Training
Cambridge Health AllianceResidency, Psychiatry, 2010 - 2014
Rutgers Robert Wood Johnson Medical SchoolClass of 2010
Brandeis UniversityM.A., Bible and Ancient Near Eastern Studies, 2004 - 2005
Brandeis UniversityB.A., Biology, Bible and Ancient Near Eastern Studies, Magna Cum Laude, 2000 - 2004
Certifications & Licensure
DC State Medical License 2026 - 2028
MA State Medical License 2013 - 2028
VA State Medical License 2026 - 2028
MD State Medical License 2026 - 2027
NJ State Medical License 2026 - 2027
NY State Medical License 2026 - 2027
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Resident Teaching Award Harvard Medical School, 2011
- Medical Student Teaching Award Harvard Medical School, 2011
- Robert Wood Johnson Medical School Psychiatric Achievement Award Robert Wood Johnson Medical School, 2010
Publications & Presentations
PubMed
- What matters in next-generation implanted neurotechnology design? Perspectives from individuals with treatment-refractory depression.Juhi Farooqui, Jonah Toennies, Landan M Mintch, Jonathan Nelson, Benjamin Yudkoff
Journal of Neural Engineering. 2026-09-08 - 4 citationsEmpowering understanding: navigating consent to ketamine treatment in adolescent mental health.Aakash Sathappan, Benjamin Yudkoff
Frontiers in Psychiatry. 2024-01-01 - 14 citationsThe therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review.Charlotte E Goldfine, Jeremiah J Tom, Dana D Im, Benjamin Yudkoff, Amit Anand
Frontiers in Psychiatry. 2023-01-01
Abstracts/Posters
- A New Syllabus for Teaching Schizophrenia to ResidentsYudkoff B, Harvard Day, 1/1/2014
Lectures
- A Psychopharmacological Review for the Non-Prescriber: How Medications Impact TherapyBrigham and Women's Faulkner Hospital - 1/1/2017
- Electroconvulsive TherapyHarvard Medical School - 1/1/2017
- Treatment of Depression: Innovations from the FieldBrigham and Women's Faulkner Hospital - 1/1/2017
Other
- O brasileiro esta dormindo maLCohen P, Yudkoff B, Brazilian Magazine
1/10/2010 - Psychological Profile of Malaysia's Datuk Seri AnwarlbrahimPost J, Yudkoff B, Privately published article
1/1/2009 - Psychological Profile of Sudan's President Omar Hassan al Bashir. Financed by the International Criminal Court in its case against President Omar Hassan al BashirPost J, Yudkoff B
1/1/2009
Authored Content
- What I Tell Clinicians Who Ask if Their Patient Is "Depressed Enough" For EsketamineJune 2026
Press Mentions
Americans Are Using Ketamine to Treat Depression with Lack of Government RegulationNovember 22nd, 2022
Americans Take Ketamine at Home for Depression with Little OversightOctober 30th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: